Rifaximin exerts beneficial effects in PI-IBS mouse model beyond gut microbiota
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.13841
Abstract: Background and aims Rifaximin is a minimally absorbed antibiotic which has shown efficacy in irritable bowel syndrome (IBS) patients. However, the mechanism how it effects in IBS is still incompletely defined. In this study, we… read more here.
Keywords: model; mouse model; rifaximin; ibs mouse ... See more keywords